Search PubMed⌕ Search

Biomedical subjects

J Orgiazzi

Publications and source records attributed to J Orgiazzi.

At least 145 records · Page 8Linked to original sources

Effects of diabetes type and treatment on zinc status in diabetes mellitus.

Zinc status was assessed in 53 diabetic patients: 18 insulin-dependent diabetic patients (IDDM), 22 noninsulin-dependent diabetic patients (NIDDM) treated with oral antidiabetic agents, and 13 insulin-treated, noninsulin-dependent diabetic patients (IRDM). Plasma zinc concentrations were in the usual range for healthy subjects in these three groups (15.3 +/- 0.9 mumol/L). Urinary zinc excretions were elevated in the IDDM group (18.3 +/- 4.1 mumol/24 h; p less than 0.01 vs normal) and in the NIDDM group (17.5 +/- 3.5 mumol/24 h; p less than 0.01 vs normal), but normal in the IRDM group (11.3 +/- 2.4 mumol/24 h). In 14 NIDDM patients treated with transient continuous sc insulin injections, urinary zinc decreased from 16.5 +/- 2.2 mumol/24 h before insulin treatment to 11.5 +/- 0.3 mumol/24 h after insulin treatment without any modification in plasma zinc concentrations.

Blood Glucose↗

[Physiopathology of non-insulin-dependent diabetes: current data and therapeutic consequences].

Non insulin-dependent diabetes mellitus results from the combination in varying proportions of low plasma insulin levels (insulinopenia), peripheral resistance to insulin and increased hepatic glucose production. Abnormalities of insulin secretion can be demonstrated without and after stimulation. Insulin resistance mainly occurs in skeletal muscle and is primarily due to a "postreceptor" defect. A pancreatic peptide, amylin, may participate in insulin resistance. Hepatic glucose production correlates with high fasting plasma glucose concentrations. Whatever its initial mechanism, hyperglycaemia maintains low insulin secretion and insulin resistance by its toxicity. In the light of these data, the effects of weight loss in obese non insulin-dependent diabetics have become clearer. The action of biguanides on insulin sensitivity is confirmed. Sulphonylureas have a pancreatic and an extrapancreatic action. The normoglycaemia obtained by intermittent insulin therapy can break the vicious circle of glucose toxicity. The use of prolonged insulin therapy is discussed. Finally, new compounds with an original mode of action offer hopes for the future.

Amyloid↗

[Comparison of the effect of TSH and fluoride on the adenylate cyclase activity of cold thyroid nodules (author's transl)].

Using a simple and reliable assay technique in which the actuel amount of cyclic AMP generated during incubation is determined by competitive protein binding assay, adenylate cyclase activity was measured in 7 cold nodules and 3 samples of normal thyroid tissue. Mitochondrial fraction prepared from surgically obtained tissues was used as the source of the enzyme. We observed an increased adenylate cyclase activity in cold nodules as compared to normal. More importantly, this activity was much more responsive to TSH in cold nodules than in normal (maximal stimulation: 1050+/-200% vs 320+/-120%). Also, maximal TSH stimulation was similar to that elucited by fluoride in the cold nodules but only one-third in normal tissue. These results suggest that higher efficiency of TSH in cold nodules may be related to increased TSH binding or coupling of TSH receptors with the caralytic subunit of adenylate cyclase.

Adenoma↗

[Risk factors of non-proliferating retinopathy in insulin-dependent diabetes].

Risk factors for non proliferative retinopathy were investigated by comparing two groups of insulin dependent diabetic patients: group NR of 25 patients without retinopathy and group R of 25 patients studied at the time of discovery of non proliferative retinopathy. The two groups were matched for age, sex and diabete duration. They were significantly different for insulin treatment regimens, blood glucose control and blood pressure. Lipid parameters and renal function were similar in the two groups.

Adult↗